THE RELATIONSHIP BETWEEN COGNITIVE IMPAIRMENT AND THE LEVEL OF NEUROLOGICAL DEFICIT IN PATIENTS WITH RRMS
DOI:
https://doi.org/10.32782/2226-2008-2025-1-10Keywords:
multiple sclerosis, cognitive function, EDSS, Schulte test Luria, test short-term memoryAbstract
Multiple sclerosis (MS) is a severe chronic disease with a complex pathogenesis characterized by a wide range of clinical manifestations, among which cognitive and motor disorders are especially pronounced. The aim of the present article is to study the relationship between the degree of neurological deficit and cognitive functions in patients with relapsing multiple sclerosis. The Expanded Disability Status Scale (EDSS) was used to assess neurological deficit, and cognitive functions were analyzed through the Schulte test and the Luria test "Memorizing 10 words". The study included 93 patients with RRMS, who were divided into two groups depending on the level of EDSS (group 1: EDSS < 3 points – 43 patients; group 2: EDSS ≥ 3 points – 50 patients). The research findings uncovered major disparities amongst the clusters. Individuals with an EDSS score ≥ 3 points demonstrated notably weaker outcomes in cognitive evaluations compared to individuals with less severe neurological conditions. The velocity of the Schulte test was significantly slowed down in this cluster, reflecting the exhaustion of cognitive resources. Furthermore, recall assessments indicated troubles in keeping facts within short-term memory, predominantly under the conditions of repetitious tasks. These cognitive deficits showed interrelation with the level of neurological impairment and the advancement of the illness. Conclusions: The study proves that the level of neurological impairment strongly influences the cognitive status of MS patients. Those with a higher EDSS score demonstrate significantly poorer performance on tests measuring attention, memory, and processing speed. Such an effect is particularly evident in test situations that require high concentrations and repetitions of tasks. The findings underscore the urgent need to integrate cognitive assessments into routine monitoring of MS patients.
References
Cuerda-Ballester M, Martínez-Rubio D, García-Pardo MP, et al. Relationship of Motor Impairment with Cognitive and Emotional Alterations in Patients with Multiple Sclerosis. Int J Environ Res Public Health. 2023; 20(2):1387. Published 2023 Jan 12. doi:10.3390/ijerph20021387
Garg N, Smith TW. An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis. Brain Behav. 2015;5(9):e00362. doi:10.1002/brb3.362
Silveira SL, Cederberg KLJ, Jeng B, et al. Symptom clusters and quality of life in persons with multiple sclerosis across the lifespan. Qual Life Res. 2021;30(4):1061-1071. doi:10.1007/s11136-020-02689-x
Eshaghi A, Prados F, Brownlee WJ, et al. Deep gray matter volume loss drives disability worsening in multiple sclerosis. Ann Neurol. 2018;83(2):210-222. doi:10.1002/ana.25145
Storm FA, Nair KPS, Clarke AJ, Van der Meulen JM, Mazzà C. Free-living and laboratory gait characteristics in patients with multiple sclerosis. PLoS One. 2018;13(5):e0196463. Published 2018 May 1. doi:10.1371/journal.pone.0196463
Radetz A, Mladenova K, Ciolac D, et al. Linking Microstructural Integrity and Motor Cortex Excitability in Multiple Sclerosis. Front Immunol. 2021;12:748357. Published 2021 Oct 12. doi:10.3389/fimmu.2021.748357
Matias-Guiu JA, Cortés-Martínez A, Valles-Salgado M, et al. Functional Components of Cognitive Impairment in Multiple Sclerosis: A Cross-Sectional Investigation. Front Neurol. 2017;8:643. Published 2017 Nov 28. doi:10.3389/fneur.2017.00643
Hankomäki E, Multanen J, Kinnunen E, Hämäläinen P. The progress of cognitive decline in newly diagnosed MS patients. Acta Neurol Scand. 2014;129(3):184-191. doi:10.1111/ane.12161
Yigit P, Acikgoz A, Mehdiyev Z, Dayi A, Ozakbas S. The relationship between cognition, depression, fatigue, and disability in patients with multiple sclerosis. Ir J Med Sci. 2021;190(3):1129-1136. doi:10.1007/s11845-020-02377-2
Core R Team. A Language and Environment for Statistical Computing. Vienna: Foundation for Statistical Computing; 2024. Available from: https://www.R-project.org.
Bates D, Mächler M, Bolker B, Walker S. Fitting Linear Mixed-Effects Models Using lme4. Journal of Statistical Software. 2015;67(1):1-48. DOI: doi.org/10.18637/jss.v067.i01.
Spivak Y. Neurodegeneration and Cognitive Dysfunction in Multiple Sclerosis. Reports of Vinnytsia National Medical University, 2024;28(3):550-561. doi: 10.31393/reports-vnmedical-2024-28(3)-29
Gudzhenko GV. Cognitive impairments in multiple sclerosis. Ukrainsʹkyi Nevrologichnyi Zhurnal. 2020;4:37-42. doi: 10.30978/UNJ2020-4-37. (In Ukrainian).
Teslenko O, Tovazhnianska O. Clinical features of cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. Visnyk Kharkivsʹkoho Natsionalʹnoho Universytetu imeni VN Karazina. Seriia Medytsyna. 2024;32(1(48):28-39. doi: 10.26565/2313-6693-2024-48-03. (In Ukrainian).
Odintsova TA. Features of cognitive impairments in multiple sclerosis patients depending on various risk factors. Psykhiatriia, Nevrolohiia ta Medychna Psykholohiia. 2021;18:39-48. doi: 10.26565/2312-5675-2021-18-03. (In Ukrainian).
Achiron A, Chapman J, Magalashvili D, et al. Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study. PLoS One. 2013;8(8):e71058. doi:10.1371/journal.pone.0071058
Kalb R, Beier M, Benedict RH, Charvet L, Costello K, Feinstein A, et al. Recommendations for cognitive screening and management in multiple sclerosis care. Mult Scler. 2018;24(13):1665-1680. doi:10.1177/1352458518803785
Sehanovic A, Smajlovic D, Tupkovic E, et al. Cognitive Disorders in Patients with Multiple Sclerosis. Mater Sociomed. 2020;32(3):191-195. doi:10.5455/msm.2020.32.191-195
Potapov O, Kmyta O, Tsyndrenko O, Makeyenk I, Sumtsova K, Nikolaenko Y. Peculiarities of the course, diagnosis, and treatment of multiple sclerosis. Eastern Ukrainian Medical Journal. 2022;10(4):389-398. doi.org/10.21272/eumj.2022;10(4):389-398
Shulga OD. Structural changes in the brain in patients with early multiple sclerosis. Odesa Medical Journal. 2019;2-3:35-39. Available at:https://files.odmu.edu.ua/journal/OMJ_2019.0203/m192-3_35.pdf